Stanford Blood Center Receives FDA Approval to Distribute Licensed COVID-19 Convalescent Plasma Nationwide
PALO ALTO, Calif. — October 15, 2025 — Stanford Blood Center (SBC) has received approval from the U.S. Food and Drug Administration (FDA) for national distribution of COVID-19 Convalescent Plasma (CCP) for the treatment of immunocompromised patients, making SBC the first blood center in California and only the second in the nation to secure this authorization under a Biologics License Application (BLA). READ MORE
